Nanoparticles that enable both MRI and fluorescent imaging could monitor cancer, other diseases.
MIT chemists have developed new nanoparticles that can
simultaneously perform magnetic resonance imaging (MRI) and fluorescent imaging
in living animals. Such particles could help scientists to track specific
molecules produced in the body, monitor a tumor’s environment, or determine
whether drugs have successfully reached their targets.